Who owns ONCOCYTE CORPORATION COM?
- Ticker: IMDX
- CUSIP Number: 68235c206
Tip: Access positions for across all investors
Analyze quarterly positions in Oncocyte Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oncocyte Corporation stock
Who bought or sold ONCOCYTE CORPORATION COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Broadwood Capital | 13M | $75M | 6% | Jun 2026 |
|
| AWM Investment Company | 2.8M | $17M | 1% | Jun 2026 |
|
| Vanguard Capital Management | 736k | $4.3M | 37% | Jun 2026 |
|
| Pura Vida Investments | 485k | $2.9M | -49% | Jun 2026 |
|
| Family Office Research | 369k | $2.2M | 190% | Jun 2026 |
|
| Geode Capital Management | 257k | $1.5M | -2% | Jun 2026 |
|
| FNY Investment Advisers | 183k | $1.1M | -26% | Jun 2026 |
|
| Jane Street | 158k | $930k | 100% | Jun 2026 |
|
| BlackRock | 151k | $888k | 11% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 125k | $735k | -6% | Jun 2026 |
|
| Millennium Management | 83k | $487k | -20% | Jun 2026 |
|
| UBS Group | 53k | $314k | 134% | Jun 2026 |
|
| State Street Corporation | 51k | $167k | 6% | Mar 2026 |
|
| Northern Trust | 49k | $290k | 0% | Jun 2026 |
|
| Advisor Group Holdings | 39k | $231k | 62% | Jun 2026 |
|
| Morgan Stanley | 36k | $118k | 0% | Mar 2026 |
|
| Leucadia National Corporation | 18k | $107k | 100% | Jun 2026 |
|
| Marshall Wace | 17k | $98k | 100% | Jun 2026 |
|
| ExodusPoint Capital Management | 14k | $83k | 100% | Jun 2026 |
|
| Axq Capital | 13k | $79k | 100% | Jun 2026 |
|
| Flatrock Wealth Partners | 13k | $77k | 0% | Jun 2026 |
|
| Two Sigma Investments | 11k | $66k | 100% | Jun 2026 |
|
| XTX Topco | 11k | $63k | -65% | Jun 2026 |
|
| Private Advisor | 10k | $62k | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 5.8k | $34k | 8964% | Jun 2026 |
|
| Vanguard Global Advisers | 5.8k | $34k | 0% | Jun 2026 |
|
| EverSource Wealth Advisors | 5.0k | $30k | 0% | Jun 2026 |
|
| Tower Research Capital | 2.7k | $16k | 100% | Jun 2026 |
|
| Steward Partners Investment Advisory | 2.0k | $12k | 100% | Jun 2026 |
|
| Citigroup | 815.00 | $2.7k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 251.00 | $1.0k | 100% | Jun 2026 |
|
| SBI Securities | 185.00 | $1.1k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 154.00 | $835.003400 | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 63.00 | $339.998400 | 100% | Jun 2026 |
|
| Caitong International Asset Management | 45.00 | $265.999500 | 4400% | Jun 2026 |
|
| Piscataqua Savings Bank | 25.00 | $147.000000 | 0% | Jun 2026 |
|
| Albion Financial Group | 7.00 | $42.000000 | 0% | Jun 2026 |
|
| Wells Fargo & Company | 7.00 | $40.999700 | 100% | Jun 2026 |
|
| Cassaday & Co Wealth Management | 6.00 | $36.000000 | -40% | Jun 2026 |
|
| Mercer Global Advisors | 5.00 | $30.000000 | 100% | Jun 2026 |
|
| Farther Finance Advisors | 1.00 | $6.000000 | 0% | Jun 2026 |
|
| Global Retirement Partners | 1.00 | $6.000000 | 0% | Jun 2026 |
|
Who sold out of Oncocyte Corporation?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Mar 2026 | 841k | $2.8M |
| Heights Capital Management | Mar 2026 | 393k | $1.3M |
| Ghisallo Capital Management | Mar 2026 | 71k | $232k |
| Susquehanna International | Mar 2026 | 56k | $184k |
| 683 Capital Management | Mar 2026 | 29k | $95k |
| Qube Research & Technologies | Mar 2026 | 25k | $83k |
| Engineers Gate Manager | Mar 2026 | 18k | $60k |
| Point72 Asset Management | Mar 2026 | 12k | $40k |
| OMERS Administration Corporation | Mar 2026 | 11k | $34k |
| Advisory Services Network | Mar 2026 | 3.1k | $10k |
| Golden State Equity Partners | Mar 2026 | 450.00 | $1.5k |
| Federation des caisses Desjardins du Quebec | Mar 2026 | 1.00 | $3.000000 |